Satellite Chemical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Operating Revenue	44,544	42,049	40,237	36,766	28,214	10,196
Other Revenue	3,600	3,600	1,250	276.78	343.13	576.42
Revenue	48,144	45,648	41,487	37,043	28,557	10,773
Revenue Growth (YoY)	15.42%	10.03%	12.00%	29.72%	165.09%	-0.06%
Cost of Revenue	37,349	34,922	33,266	30,922	19,515	7,681
Gross Profit	10,794	10,726	8,221	6,121	9,042	3,092
Selling, General & Admin	909.5	885.01	676.09	628.75	569.6	542.73
Research & Development	1,702	1,751	1,626	1,241	1,075	480.73
Other Operating Expenses	123.02	3.12	0.15	120.01	95.15	13.71
Operating Expenses	2,715	2,653	2,304	2,005	1,751	1,040
Operating Income	8,079	8,073	5,917	4,116	7,290	2,052
Interest Expense	-1,009	-1,082	-1,208	-429.66	-557.07	-202.18
Interest & Investment Income	418.36	167.33	224.77	578.83	267.9	63.86
Currency Exchange Gain (Loss)	-86.45	-86.45	197.02	-130.66	18.32	-12.72
Other Non Operating Income (Expenses)	-6.91	-23.48	-24.47	-457.78	-39.72	-37.53
EBT Excluding Unusual Items	7,395	7,048	5,105	3,677	6,980	1,863
Gain (Loss) on Sale of Investments	-97.35	157.12	173.59	-290.56	-31.05	21.01
Gain (Loss) on Sale of Assets	10.36	0	0.47	2.93	0.38	0.28
Asset Writedown	-242.67	-261.18	-13.55	-4.59	-38.95	-0.02
Legal Settlements	-	-	-	-	-	-3.61
Other Unusual Items	73.65	73.65	102.17	60.07	82.96	26.43
Pretax Income	7,139	7,018	5,368	3,445	6,993	1,907
Income Tax Expense	1,010	956.12	584.27	334.42	980.41	249.59
Earnings From Continuing Operations	6,129	6,062	4,784	3,111	6,013	1,658
Net Income to Company	6,129	6,062	4,784	3,111	6,013	1,658
Minority Interest in Earnings	5.12	9.88	5.74	-14.82	-6.28	3.35
Net Income	6,134	6,072	4,789	3,096	6,007	1,661
Net Income to Common	6,134	6,072	4,789	3,096	6,007	1,661
Net Income Growth	21.43%	26.77%	54.71%	-48.46%	261.62%	30.50%
Shares Outstanding (Basic)	3,388	3,368	3,373	3,365	3,356	2,985
Shares Outstanding (Diluted)	3,388	3,369	3,373	3,365	3,374	3,013
Shares Change (YoY)	0.59%	-0.13%	0.24%	-0.28%	12.00%	2.71%
EPS (Basic)	1.81	1.80	1.42	0.92	1.79	0.56
EPS (Diluted)	1.81	1.80	1.42	0.92	1.78	0.55
EPS Growth	20.55%	26.76%	54.35%	-48.32%	222.87%	27.06%
Free Cash Flow	9,624	7,450	5,590	1,971	-394.89	-5,797
Free Cash Flow Per Share	2.84	2.21	1.66	0.59	-0.12	-1.92
Dividend Per Share	0.500	0.500	0.400	0.400	0.178	0.062
Dividend Growth	25.00%	25.00%	-	124.34%	187.58%	-5.49%
Gross Margin	22.42%	23.50%	19.82%	16.52%	31.66%	28.70%
Operating Margin	16.78%	17.69%	14.26%	11.11%	25.53%	19.05%
Profit Margin	12.74%	13.30%	11.54%	8.36%	21.03%	15.42%
Free Cash Flow Margin	19.99%	16.32%	13.47%	5.32%	-1.38%	-53.82%
EBITDA	11,189	10,828	8,199	5,615	8,353	2,653
EBITDA Margin	23.24%	23.72%	19.76%	15.16%	29.25%	24.62%
D&A For EBITDA	3,110	2,755	2,282	1,499	1,063	600.88
EBIT	8,079	8,073	5,917	4,116	7,290	2,052
EBIT Margin	16.78%	17.69%	14.26%	11.11%	25.53%	19.05%
Effective Tax Rate	14.15%	13.62%	10.88%	9.71%	14.02%	13.09%
Revenue as Reported	48,144	45,648	41,487	37,043	28,557	10,773

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.